Bristol-Myers Squibb is a leading pharmaceutical company with a strong pipeline. However, the stock is been stagnant in 2020 and therefore remains significantly undervalued here at the beginning of 2021. With this video I attempt to illustrate reasons why the market has been neglecting this blue-chip and then elaborate on whether it is justified or not.
— Chuck Carnevale
Millionaire Investor Says Second Boom in AI Begins Now [sponsor]Louis Navellier has been ahead of the AI market at every turn. He picked Nvidia way back in May 2019. It's up 2,011% since. He made 372% on Cadence Design and 1,810% on Super Microcomputer. Now he says a second boom in AI is about to begin.
Source: FAST Graphs
